Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2021-08-23 Regulatory Filings
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Webcast details for HLS FY 2021 Results 1 page 476.
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 24 August 2021, providing details about a webcast for the upcoming release of Healius Limited's FY 2021 results on 30 August 2021. It includes information on how to access the webcast and participate in a Q&A session. The document does not contain any financial data or the actual results but is an announcement about the forthcoming earnings release event. The document length is short (2255 characters), and it clearly states the results will be released on a future date. According to the 'MENU VS MEAL' rule, this is an announcement about the report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2021-08-23 English
Sale of Adora Fertility 1 page 464.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement regarding the sale of a business unit (Adora Fertility) by Healius Limited. It details the transaction terms, the strategic rationale, and expected completion timing. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a corporate announcement about a capital transaction (sale of assets/business segment). This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including asset sales.
2021-08-22 English
Becoming a substantial holder 3 pages 64.2KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001. It details the substantial shareholding of Vinva Investment Management in Healius Limited, including voting power, relevant interests, registered holders, and consideration paid. This type of filing is a notification of a major shareholding change, specifically the acquisition of a substantial interest in a company. It is not a financial report, management announcement, or other types of filings. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2021-07-25 English
Imaging - rebrand as Lumus Imaging and purchase of Axis 2 pages 476.2KB
M&A Activity Classification · 95% confidence The document is an ASX announcement dated 12 July 2021 regarding Healius' Imaging Division acquiring Axis Diagnostics and rebranding as Lumus Imaging. It discusses the acquisition details, strategic rationale, and rebranding plans. There are no financial statements, earnings data, or detailed financial analysis present. The document is a corporate announcement about a business acquisition and rebranding, which fits the category of M&A Activity (TAR) as it relates to merger and acquisition announcements. The document length is 3358 characters, which is typical for an announcement rather than a full report. Therefore, the appropriate classification is TAR with high confidence.
2021-07-11 English
Application for quotation of securities - HLS 6 pages 28.0KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the securities, issue dates, and the nature of the issuance (performance rights vesting). This is a capital market transaction announcement related to securities issuance and quotation, not a financial report or management discussion. It fits the definition of a Share Issue/Capital Change announcement, as it informs about new shares being issued and quoted on the exchange.
2021-07-08 English
Clarification of Appendix 2A - number of HLS ORD on issue 1
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement clarifying details about an Appendix 2A form related to the number of ordinary shares on issue, including shares bought back and cancelled. Appendix 2A is a form used for share issue notifications in the Australian market. The content focuses on share capital details and corrections to previously lodged forms. The document is short (1575 characters) and is an announcement rather than a full report or financial statement. This fits the category of Share Issue/Capital Change announcements, which cover new share issues, stock splits, or other capital changes.
2021-07-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.